Form 8-K - Current report:
SEC Accession No. 0001564590-20-004243
Filing Date
2020-02-11
Accepted
2020-02-11 17:16:58
Documents
14
Period of Report
2020-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20200211.htm   iXBRL 8-K 37895
2 EX-99.1 fgen-ex991_6.htm EX-99.1 19734
3 GRAPHIC gwzeicfshvy1000001.jpg GRAPHIC 4406
  Complete submission text file 0001564590-20-004243.txt   196126

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fgen-20200211.xsd EX-101.SCH 5968
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20200211_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20200211_pre.xml EX-101.PRE 11177
10 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20200211_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 20598107
SIC: 2834 Pharmaceutical Preparations